Original Research

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey

Petrella RJ, Gill DP, Berrou JP

Diabetes, Metabolic Syndrome and Obesity 2015, 8:173-180

Published Date: 24 March 2015